:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40011400/aabf6b76d9d1474079703c0ac0f87724_wm.png)
MAT2A Knockdown Enhances Recombinant Protein Expression in Transgenic CHO Cells Through Regulation of Cell Cycle.
Summary: Scientists have discovered a way to supercharge the microscopic "factories" used to make many modern medicines. Chinese Hamster Ovary (CHO) cells are commonly used to produce therapeutic proteins, but they often prioritize multiplying over manufacturing. In this study, researchers silenced a specific gene called MAT2A. This genetic "brake" stopped the cells from dividing (a state called G1 arrest), causing them to grow larger and boost their metabolism. The result was a nearly two-fold increase in the production of high-quality medicinal proteins, offering a more efficient way to manufacture drugs.
Tags
Neoplasms
G1 Phase
Cell Cycle Checkpoints
CHO Cells
Cyclins
Cyclin-Dependent Kinases
Recombinant Proteins
Cricetinae
Cricetulus
Cyclin-Dependent Kinase Inhibitor p21
Cell Engineering